Rivogenlecleucel
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rivogenlecleucel, covering 2023-09-01 to 2023-09-01. Get the full timeline:
Most recent: Clinical Trial Update: Study of Haplo-HSCT + Rivogenlecleucel vs Haplo-HSCT + Post Transplant Cyclophosphamide in Patients With AML or MDS [Phase 2, Phase 3]